[1]
Y. Anil Kumar and V. Chitra, “Prospects of Combinatorial Approach Involving ICD Induction and Adenosine A2A Receptor Pathway Inhibition to Improve Cancer Immunotherapy”, TI, vol. 29, no. 2, pp. 181–193, Jul. 2022.